Effects of Prompt to Bundle COVID-19 Booster and Flu Shot
1 other identifier
interventional
109,493
1 country
1
Brief Summary
This randomized controlled trial investigates whether text-based reminders can increase the bivalent COVID-19 booster uptake and whether text-based reminders that mention the opportunity to bundle the COVID-19 booster with the flu shot within the same appointment can increase take-up of both the COVID-19 booster and the flu vaccine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable covid19
Started Oct 2022
Typical duration for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2022
CompletedStudy Start
First participant enrolled
October 18, 2022
CompletedFirst Posted
Study publicly available on registry
October 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedDecember 5, 2024
December 1, 2024
2 months
October 17, 2022
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
booster take-up at UCLA/CVS in 2 weeks
Whether people receive the bivalent booster at either UCLA Health or CVS Pharmacy
2 weeks after getting the text message
booster take-up at UCLA/CVS in 4 weeks
Whether people receive the bivalent booster at either UCLA Health or CVS Pharmacy
4 week after getting the text message
Secondary Outcomes (7)
Link click rate in 1 week
1 week after getting the text message
booster take-up in 2 weeks
2 weeks after getting the text message
booster take-up in 4 weeks
4 weeks after getting the text message
Flu vaccine take-up at UCLA/CVS in 2 weeks
2 weeks after getting the text message
Flu vaccine take-up at UCLA/CVS in 4 weeks
4 weeks after getting the text message
- +2 more secondary outcomes
Study Arms (4)
Holdout
NO INTERVENTIONSimple Reminder
EXPERIMENTALFlu Tag Along
EXPERIMENTALCovid-19 Booster + Flu Bundle
EXPERIMENTALInterventions
Patients will receive a text message reminding them to enhance their protection against COVID-19 by getting the bivalent booster. The message will contain one link to schedule an appointment at UCLA Health and one link for scheduling an appointment at CVS Pharmacy.
This message will also encourage patients to protect themselves against the flu by asking for their flu vaccine at the booster appointment (at UCLA Health) or adding the flu vaccine to the COVID-19 vaccine booster appointment (at CVS).
This message will simultaneously encourage patients to enhance their protection against COVID-19 and the flu and will inform them that, to save time, they can bundle two vaccines at once. Patients will learn that at UCLA Health, they can book an appointment for the booster and then ask for the flu vaccine at their appointment; at CVS Pharmacy, they can book one appointment to get both the bivalent COVID-19 booster and the flu vaccine.
Eligibility Criteria
You may qualify if:
- Patients aged 18 or above
- Have a mobile phone number or SMS-capable phone number in UCLA Health's database
- Having completed a COVID-19 vaccine primary series based on CAIR data
- Last COVID-19 vaccine shot (including booster shot) occurred at least two months before the date when patient list are pulled in preparation for the trial, based on CAIR data. The last two criteria meant to identify patients who are eligible for the updated booster.
You may not qualify if:
- Patients who have received the bivalent booster anywhere (based on CAIR data) before the day they receive the text message
- Patients who have already scheduled appointments at UCLA Health for getting the bivalent booster before the day they receive the text message
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Health Department of Medicine, Quality Office
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 17, 2022
First Posted
October 19, 2022
Study Start
October 18, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2023
Last Updated
December 5, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share